HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RoC Cellulite-Reducing Entry Improves Condition In 39% Of Women Tested

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson is extending its RoC anti-aging skin care line with a new product to address cellulite concerns. In consumer testing, women who used Retinol Actif Pur Anti-Cellulite Treatment noticed a 39% improvement in the condition after eight weeks, the company said.

You may also be interested in...



J&J DMAE Anti-Aging Skin Benefits Research Promoted At AAD Meeting

Several Johnson & Johnson studies on dimethylaminoethanol (DMAE) as a topical anti-aging skin care ingredient were presented at the American Academy of Dermatology annual meeting in New Orleans Feb. 22-27

J&J DMAE Anti-Aging Skin Benefits Research Promoted At AAD Meeting

Several Johnson & Johnson studies on dimethylaminoethanol (DMAE) as a topical anti-aging skin care ingredient were presented at the American Academy of Dermatology annual meeting in New Orleans Feb. 22-27

Neutrogena Visibly Firm Takes Elemental Approach With Active Copper

Neutrogena Visibly Firm Night and Eye creams employ the nutrient copper to restore skin firmness and regain measurably smooth, buoyant skin, the Johnson & Johnson division said at a press event in New York City Feb. 20.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel